Simpson, A. J., Bood, J. R., Anderson, S. D., Romer, L. M., Dahlén, B, Dahlén, S.-E & Kippelen, P. (2016). A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes. Journal of Applied Physiology, 120 (9), 1011-1017. Zugriff am 03.05.2017 unter http://doi.org/10.1152/japplphysiol.00700.2015
APA-Zitierstil (7. Ausg.)Simpson, A. J., Bood, J. R., Anderson, S. D., Romer, L. M., Dahlén, B., Dahlén, S., & Kippelen, P. (2016). A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletes. Journal of Applied Physiology, 120(9), 1011-1017.
Chicago-Zitierstil (17. Ausg.)Simpson, A. J., J. R. Bood, S. D. Anderson, L. M. Romer, B. Dahlén, S.-E Dahlén, und P. Kippelen. "A Standard, Single Dose of Inhaled Terbutaline Attenuates Hyperpnea-induced Bronchoconstriction and Mast Cell Activation in Athletes." Journal of Applied Physiology 120, no. 9 (2016): 1011-1017.
MLA-Zitierstil (9. Ausg.)Simpson, A. J., et al. "A Standard, Single Dose of Inhaled Terbutaline Attenuates Hyperpnea-induced Bronchoconstriction and Mast Cell Activation in Athletes." Journal of Applied Physiology, vol. 120, no. 9, 2016, pp. 1011-1017.